Xenetic Biosciences releases investor presentation with a proposed transaction
Xenetic Biosciences has filed an exhibit containing a proposed transaction discussion and forward-looking statements, with both companies targeting a Nasdaq listing post-merger.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed